Casey Woodring
Stock Analyst at JP Morgan
(0.35)
# 4,054
Out of 4,761 analysts
31
Total ratings
15.79%
Success rate
-18.93%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Neutral | $175 → $165 | $163.02 | +1.21% | 7 | Feb 20, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $280 → $265 | $201.39 | +31.59% | 5 | Feb 3, 2025 | |
| HOLX Hologic | Maintains: Overweight | $92 → $94 | $64.49 | +45.76% | 5 | Nov 5, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $54 → $56 | $39.57 | +40.56% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $3.80 | +57.89% | 3 | May 13, 2024 | |
| QDEL QuidelOrtho | Downgrades: Underweight | $66 → $37 | $40.46 | -8.55% | 3 | Feb 14, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $22.77 | +1.01% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $13.52 | +33.14% | 2 | Jan 23, 2023 |
Charles River Laboratories International
Feb 20, 2025
Maintains: Neutral
Price Target: $175 → $165
Current: $163.02
Upside: +1.21%
ICON Public Limited Company
Feb 3, 2025
Maintains: Overweight
Price Target: $280 → $265
Current: $201.39
Upside: +31.59%
Hologic
Nov 5, 2024
Maintains: Overweight
Price Target: $92 → $94
Current: $64.49
Upside: +45.76%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $54 → $56
Current: $39.57
Upside: +40.56%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $3.80
Upside: +57.89%
QuidelOrtho
Feb 14, 2024
Downgrades: Underweight
Price Target: $66 → $37
Current: $40.46
Upside: -8.55%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $22.77
Upside: +1.01%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $13.52
Upside: +33.14%